Mundipharma Research Limited

This early-phase study tested a new drug called tinostamustine in 10 people with a fast-growing brain cancer (glioblastoma) that has a specific genetic marker (unmethylated MGMT). The goal was to see if the drug is safe and how the body processes it, given after standard treatmen…

This study tested whether a new drug called rezafungin can prevent serious fungal infections in adults receiving a bone marrow transplant. About 600 participants were given either rezafungin or the standard treatment. The goal was to see if rezafungin is safer and works better at…